![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EPS15L1 |
Gene summary for EPS15L1 |
![]() |
Gene information | Species | Human | Gene symbol | EPS15L1 | Gene ID | 58513 |
Gene name | epidermal growth factor receptor pathway substrate 15 like 1 | |
Gene Alias | EPS15R | |
Cytomap | 19p13.11 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q9UBC2 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
58513 | EPS15L1 | LZE4T | Human | Esophagus | ESCC | 1.83e-13 | 3.27e-01 | 0.0811 |
58513 | EPS15L1 | LZE7T | Human | Esophagus | ESCC | 6.50e-11 | 6.67e-01 | 0.0667 |
58513 | EPS15L1 | LZE8T | Human | Esophagus | ESCC | 4.44e-03 | 7.68e-02 | 0.067 |
58513 | EPS15L1 | LZE20T | Human | Esophagus | ESCC | 2.77e-03 | 1.42e-01 | 0.0662 |
58513 | EPS15L1 | LZE21D1 | Human | Esophagus | HGIN | 1.77e-02 | 1.84e-01 | 0.0632 |
58513 | EPS15L1 | LZE24T | Human | Esophagus | ESCC | 2.31e-15 | 3.59e-01 | 0.0596 |
58513 | EPS15L1 | LZE21T | Human | Esophagus | ESCC | 7.93e-03 | 2.32e-01 | 0.0655 |
58513 | EPS15L1 | P1T-E | Human | Esophagus | ESCC | 2.36e-08 | 3.71e-01 | 0.0875 |
58513 | EPS15L1 | P2T-E | Human | Esophagus | ESCC | 7.50e-21 | 1.98e-01 | 0.1177 |
58513 | EPS15L1 | P4T-E | Human | Esophagus | ESCC | 1.86e-15 | 3.19e-01 | 0.1323 |
58513 | EPS15L1 | P5T-E | Human | Esophagus | ESCC | 2.43e-16 | 2.11e-01 | 0.1327 |
58513 | EPS15L1 | P8T-E | Human | Esophagus | ESCC | 7.81e-23 | 3.49e-01 | 0.0889 |
58513 | EPS15L1 | P9T-E | Human | Esophagus | ESCC | 3.62e-17 | 2.33e-01 | 0.1131 |
58513 | EPS15L1 | P10T-E | Human | Esophagus | ESCC | 2.21e-32 | 4.95e-01 | 0.116 |
58513 | EPS15L1 | P11T-E | Human | Esophagus | ESCC | 1.89e-16 | 3.83e-01 | 0.1426 |
58513 | EPS15L1 | P12T-E | Human | Esophagus | ESCC | 3.65e-23 | 4.42e-01 | 0.1122 |
58513 | EPS15L1 | P15T-E | Human | Esophagus | ESCC | 8.60e-14 | 2.86e-01 | 0.1149 |
58513 | EPS15L1 | P16T-E | Human | Esophagus | ESCC | 3.20e-15 | 2.56e-01 | 0.1153 |
58513 | EPS15L1 | P17T-E | Human | Esophagus | ESCC | 1.17e-06 | 2.85e-01 | 0.1278 |
58513 | EPS15L1 | P19T-E | Human | Esophagus | ESCC | 1.36e-02 | 3.61e-01 | 0.1662 |
Page: 1 2 3 4 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001619710 | Esophagus | HGIN | endosomal transport | 57/2587 | 230/18723 | 5.74e-06 | 1.81e-04 | 57 |
GO:001619715 | Esophagus | ESCC | endosomal transport | 168/8552 | 230/18723 | 2.28e-17 | 1.93e-15 | 168 |
GO:001619718 | Thyroid | PTC | endosomal transport | 128/5968 | 230/18723 | 6.26e-14 | 3.52e-12 | 128 |
GO:001619719 | Thyroid | ATC | endosomal transport | 128/6293 | 230/18723 | 4.44e-12 | 1.75e-10 | 128 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0414429 | Esophagus | HGIN | Endocytosis | 76/1383 | 251/8465 | 1.74e-08 | 3.34e-07 | 2.65e-07 | 76 |
hsa04144113 | Esophagus | HGIN | Endocytosis | 76/1383 | 251/8465 | 1.74e-08 | 3.34e-07 | 2.65e-07 | 76 |
hsa04144210 | Esophagus | ESCC | Endocytosis | 186/4205 | 251/8465 | 9.74e-16 | 4.66e-14 | 2.39e-14 | 186 |
hsa0414437 | Esophagus | ESCC | Endocytosis | 186/4205 | 251/8465 | 9.74e-16 | 4.66e-14 | 2.39e-14 | 186 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EPS15L1 | SNV | Missense_Mutation | novel | c.1570G>A | p.Val524Ile | p.V524I | Q9UBC2 | protein_coding | tolerated(0.44) | benign(0.003) | TCGA-VQ-A8P2-01 | Stomach | stomach adenocarcinoma | Male | >=65 | III/IV | Unspecific | Complete Response | |
EPS15L1 | SNV | Missense_Mutation | rs771110967 | c.265N>A | p.Val89Ile | p.V89I | Q9UBC2 | protein_coding | tolerated(0.23) | benign(0.007) | TCGA-BJ-A0ZB-01 | Thyroid | thyroid carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
EPS15L1 | insertion | Frame_Shift_Ins | novel | c.1798_1799insATAAAACACACAGT | p.Pro600HisfsTer133 | p.P600Hfs*133 | Q9UBC2 | protein_coding | TCGA-EL-A3ZG-01 | Thyroid | thyroid carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 8 9 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |